Peptidi

A synthetic peptide for use as a blocking control in assays to test for specificity of RP13-102H20.1 antibody, catalog no. 70R-7538

A synthetic peptide for use as a blocking control in assays to test for specificity of CENPI antibody, catalog no. 70R-3284

A synthetic peptide for use as a blocking control in assays to test for specificity of Thra antibody, catalog no. 70R-8055

A synthetic peptide for use as a blocking control in assays to test for specificity of HERPUD2 antibody, catalog no. 70R-6631

A synthetic peptide for use as a blocking control in assays to test for specificity of SGK1 antibody, catalog no. 70R-6014

A synthetic peptide for use as a blocking control in assays to test for specificity of OR2W5 antibody, catalog no. 70R-6775

A synthetic peptide for use as a blocking control in assays to test for specificity of BLMH antibody, catalog no. 70R-2880

A synthetic peptide for use as a blocking control in assays to test for specificity of ALAD antibody, catalog no. 70R-3444

A synthetic peptide for use as a blocking control in assays to test for specificity of MIF4GD antibody, catalog no. 70R-1452

A synthetic peptide for use as a blocking control in assays to test for specificity of BC37295_3 antibody, catalog no. 70R-8171

A synthetic peptide for use as a blocking control in assays to test for specificity of HAX1 antibody, catalog no. 70R-2545

A synthetic peptide for use as a blocking control in assays to test for specificity of PNPLA4 antibody, catalog no. 70R-5369

A synthetic peptide for use as a blocking control in assays to test for specificity of FBXO28 antibody, catalog no. 70R-3153

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC25A46 antibody, catalog no. 70R-1747

A synthetic peptide for use as a blocking control in assays to test for specificity of SETD7 antibody, catalog no. 70R-1046

MSH-Release Inhibiting Factor (MRIF) has been shown to be a potent inhibitor of the release of proinflammatory cytokines. It is derived from the acid methyl ester of mouse serum, and has been shown to inhibit the release of tumor necrosis factor-α (TNF-α) in animal studies. MRIF has also been shown to have anti-diabetic effects in mice. MRIF inhibits the production of inflammatory cytokines by blocking TNF-α at a molecular level. This protein binds to progesterone receptor and prevents it from interacting with its ligand, which is necessary for cancer cell growth. The expression system for this protein is E. coli, and it can be used as an immunosuppressant in animal studies.
MRIF also blocks TNF-α activity by inhibiting transcriptional activation of NFκB and AP-1, which are proteins that regulate gene expression.

A synthetic peptide for use as a blocking control in assays to test for specificity of SYVN1 antibody, catalog no. 70R-1869

A synthetic peptide for use as a blocking control in assays to test for specificity of HERC5 antibody, catalog no. 70R-5524

A synthetic peptide for use as a blocking control in assays to test for specificity of ST6GALNAC6 antibody, catalog no. 70R-6867

A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM16C antibody, catalog no. 70R-6548